-
Geron Corporation (GERN $1.31)
- $1.31 Cap: $783M
- View GERN Profile
- View Questions on GERN
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Geron Corporation (GERN $1.31)
- $1.31 Cap: $783M
- View GERN Profile
- View Questions on GERN
Q: Gern has been trending down since its spike up after getting FDA approval. Is this a typical quiet period for a biotech before revenues begin? Can I get your perspective on Gern, please.
-
Telo Genomics Corp. (TELO)
- P/E (TTM): -21.9X Cap: $2M
- View TELO Profile
- View Questions on TELO
-
Denali Therapeutics Inc. (DNLI $14.52)
- $14.52 Cap: $2.03B
- View DNLI Profile
- View Questions on DNLI
-
Geron Corporation (GERN $1.31)
- $1.31 Cap: $783M
- View GERN Profile
- View Questions on GERN
Q: I keep hearing the word longevity these days. Seems people are living longer so I think there must be some investments I can make to take advantage of this trend. Please give me the names of some companies that are involved in helping people live longer lives and at the same time provide drugs or technologies or therapies that help them enjoy longer lives characterized by a higher quality of life. I'm interested in both American/global companies and Canadian.
-
Geron Corporation (GERN $1.31)
- $1.31 Cap: $783M
- View GERN Profile
- View Questions on GERN
Q: seems like a bit of a long shot high volume some analysts have high expectations could you comment please?
Insiders
Share Information
SEC Filings
News and Media